- Home
- ATXS vs VREX Comparison
ATXS vs VREX Comparison
Compare ATXS & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- VREX
- Stock Information
- Founded
- ATXS 2008
- VREX 2016
- Country
- ATXS United States
- VREX United States
- Employees
- ATXS N/A
- VREX N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- VREX Industrial Machinery/Components
- Sector
- ATXS Health Care
- VREX Technology
- Exchange
- ATXS Nasdaq
- VREX Nasdaq
- Market Cap
- ATXS 401.2M
- VREX 443.9M
- IPO Year
- ATXS 2015
- VREX N/A
- Fundamental
- Price
- ATXS $6.85
- VREX $10.87
- Analyst Decision
- ATXS Buy
- VREX Strong Buy
- Analyst Count
- ATXS 6
- VREX 2
- Target Price
- ATXS $32.00
- VREX $19.50
- AVG Volume (30 Days)
- ATXS 248.4K
- VREX 533.3K
- Earning Date
- ATXS 08-12-2025
- VREX 08-07-2025
- Dividend Yield
- ATXS N/A
- VREX N/A
- EPS Growth
- ATXS N/A
- VREX N/A
- EPS
- ATXS N/A
- VREX N/A
- Revenue
- ATXS N/A
- VREX $821,400,000.00
- Revenue This Year
- ATXS N/A
- VREX $0.73
- Revenue Next Year
- ATXS N/A
- VREX $4.40
- P/E Ratio
- ATXS N/A
- VREX N/A
- Revenue Growth
- ATXS N/A
- VREX N/A
- 52 Week Low
- ATXS $3.56
- VREX $6.76
- 52 Week High
- ATXS $12.92
- VREX $16.93
- Technical
- Relative Strength Index (RSI)
- ATXS 56.47
- VREX 78.46
- Support Level
- ATXS $6.60
- VREX $10.15
- Resistance Level
- ATXS $7.20
- VREX $10.96
- Average True Range (ATR)
- ATXS 0.47
- VREX 0.58
- MACD
- ATXS -0.03
- VREX 0.41
- Stochastic Oscillator
- ATXS 61.72
- VREX 96.48
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.